サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1546205

タンパク質アッセイの世界市場

Protein Assays

出版日
ページ情報
英文 308 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
タンパク質アッセイの世界市場
出版日: 2024年09月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 308 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

タンパク質アッセイの世界市場は2030年までに37億米ドルに到達

2023年に24億米ドルと推定されるタンパク質アッセイの世界市場は、分析期間2023-2030年にCAGR 6.3%で成長し、2030年には37億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるタンパク質アッセイキットは、CAGR 5.6％を記録し、分析期間終了時には9億3,840万米ドルに達すると予測されています。タンパク質アッセイ Instruments &Accessories分野の成長率は、分析期間中CAGR 6.2％と推定されます。

米国市場は6億3,720万米ドル、中国はCAGR 5.9％で成長予測

米国のタンパク質アッセイ市場は、2023年に6億3,720万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを5.9%として、2030年までに5億7,550万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.7%と5.2%と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界のタンパク質アッセイ市場- 主要動向と促進要因のまとめ

可能性の分析拡大するタンパク質アッセイ市場

タンパク質アッセイはライフサイエンス研究の基本ツールであり、様々な生物学的サンプル中のタンパク質の定量と分析を可能にします。これらのアッセイは、タンパク質の機能、構造、相互作用を理解するために不可欠であり、新薬、診断薬、治療法の開発に不可欠です。タンパク質の大規模研究であるプロテオミクスへの注目の高まりが、タンパク質アッセイの需要を大きく押し上げています。バイオテクノロジー、医薬品、臨床診断などの分野では、タンパク質アッセイは品質管理、創薬、疾病診断に不可欠です。慢性疾患の増加や個別化医療の必要性は、現代ヘルスケアにおける正確で信頼できるタンパク質アッセイの重要性をさらに強調しています。

技術の進歩は市場にどのような影響を与えているか？

技術の進歩は、タンパク質アッセイの進化において極めて重要な役割を果たしています。ハイスループットアッセイと自動化システムの開発は、この分野に革命をもたらし、複雑な生物学的サンプル中のタンパク質の迅速かつ正確な定量を可能にしました。蛍光および発光ベースのアッセイにおける革新は、感度と特異性を向上させ、研究者は低存在タンパク質をより正確に検出できるようになった。マイクロフルイディクスとラボオンチップ技術の統合も、効率性と拡張性を高め、様々な分野の研究者が利用しやすくなっています。さらに、バイオインフォマティクスとデータ解析ツールの進歩は、複雑なタンパク質データの解釈を容易にし、研究および臨床現場での高度なタンパク質アッセイの採用をさらに促進しています。

タンパク質アッセイの新しいアプリケーションとは？

タンパク質アッセイは、個別化医療、バイオマーカー探索、免疫療法などの新しい分野でますます応用されています。個別化医療では、タンパク質アッセイは個々の患者の標的治療の選択の指針となる特定のバイオマーカーを同定するために使用されます。また、特にがん治療における免疫療法の台頭により、免疫チェックポイントタンパク質の発現レベルを評価できるタンパク質アッセイの需要が高まっており、これらの治療法の有効性を判断するために重要な役割を担っています。さらに、タンパク質アッセイは、患者のベッドサイドで迅速かつ正確な結果を提供するポイントオブケア検査などの新しい診断ツールの開発にも使用されています。このような新たなアプリケーションの出現により、タンパク質アッセイの研究および臨床の範囲と有用性が拡大しています。

市場成長の主な促進要因は？

タンパク質アッセイ市場の成長は、いくつかの要因によって牽引されています。プロテオミクスへの注目の高まりと、タンパク質の機能や相互作用を研究するための高度なツールの必要性が、主要な促進要因です。ハイスループットや自動化アッセイの開発などの技術的進歩により、タンパク質定量の効率と精度が大幅に向上し、研究および臨床現場での採用が促進されています。慢性疾患の蔓延や個別化医療の需要も、信頼性の高いタンパク質アッセイの必要性に拍車をかけています。特にバイオマーカー探索や免疫療法における新たなアプリケーションが、市場をさらに拡大しています。さらに、高度なデータ解析ツールとバイオインフォマティクスの統合がタンパク質アッセイの有用性を高め、現代のライフサイエンス研究に欠かせないものとなっています。

調査対象企業の例（注目の11社）

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Biovision Inc.
  • Cell Signaling Technology, Inc.
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • Lonza Group AG
  • Merck KgaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP14255

Global Protein Assays Market to Reach US$3.7 Billion by 2030

The global market for Protein Assays estimated at US$2.4 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Protein Assays Kits, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$938.4 Million by the end of the analysis period. Growth in the Protein Assays Instruments & Accessories segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$637.2 Million While China is Forecast to Grow at 5.9% CAGR

The Protein Assays market in the U.S. is estimated at US$637.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$575.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Protein Assays Market - Key Trends and Drivers Summarized

Analyzing the Potential: The Expanding Market for Protein Assays

Protein assays are fundamental tools in life sciences research, enabling the quantification and analysis of proteins in various biological samples. These assays are critical for understanding protein function, structure, and interactions, which are essential for developing new drugs, diagnostics, and therapies. The increasing focus on proteomics, the large-scale study of proteins, has significantly driven the demand for protein assays. In fields such as biotechnology, pharmaceuticals, and clinical diagnostics, protein assays are indispensable for quality control, drug discovery, and disease diagnosis. The growing prevalence of chronic diseases and the need for personalized medicine further underscore the importance of accurate and reliable protein assays in modern healthcare.

How Are Technological Advancements Influencing the Market?

Technological advancements have played a pivotal role in the evolution of protein assays. The development of high-throughput assays and automated systems has revolutionized the field, enabling the rapid and accurate quantification of proteins in complex biological samples. Innovations in fluorescence and luminescence-based assays have improved sensitivity and specificity, allowing researchers to detect low-abundance proteins with greater precision. The integration of microfluidics and lab-on-a-chip technologies has also enhanced the efficiency and scalability of protein assays, making them more accessible to researchers across various disciplines. Additionally, advancements in bioinformatics and data analysis tools have facilitated the interpretation of complex protein data, further driving the adoption of advanced protein assays in research and clinical settings.

What Are the Emerging Applications of Protein Assays?

Protein assays are increasingly being applied in emerging fields such as personalized medicine, biomarker discovery, and immunotherapy. In personalized medicine, protein assays are used to identify specific biomarkers that can guide the selection of targeted therapies for individual patients. The rise of immunotherapy, particularly in cancer treatment, has also driven the demand for protein assays that can assess the expression levels of immune checkpoint proteins, which are critical for determining the efficacy of these therapies. Additionally, protein assays are being used in the development of novel diagnostic tools, such as point-of-care tests, that provide rapid and accurate results at the patient’s bedside. These emerging applications are expanding the scope and utility of protein assays in both research and clinical practice.

What Are the Key Growth Drivers in the Market?

The growth in the protein assays market is driven by several factors. The increasing focus on proteomics and the need for advanced tools to study protein function and interactions are major drivers. Technological advancements, such as the development of high-throughput and automated assays, have significantly improved the efficiency and accuracy of protein quantification, driving their adoption in research and clinical settings. The growing prevalence of chronic diseases and the demand for personalized medicine have also spurred the need for reliable protein assays. Emerging applications, particularly in biomarker discovery and immunotherapy, are further expanding the market. Additionally, the integration of advanced data analysis tools and bioinformatics is enhancing the utility of protein assays, making them indispensable in modern life sciences research.

Select Competitors (Total 11 Featured) -

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Biovision Inc.
  • Cell Signaling Technology, Inc.
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • Lonza Group AG
  • Merck KgaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • An Overview of Protein Assays Market
    • Protein Assays - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude into Market Leading Players
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in R&D Initiatives by Public and Private Companies is anticipated to Bolster Market Demand
    • Encouraging initiatives in Proteomics Research is Fuelling Worldwide Protein Assay Market
    • Rise in Biotech and Pharmaceutical R&D Expenditure Augurs Well for Market Growth
    • Global Pharmaceutical Industry: Breakdown of Total R&D Spend in USD Billion for years 2018, 2019, 2020, 2021, 2022
    • Increase in Cancer Prevalence: An Opportunity Indicator for Protein Assays Market
    • Increase in Technological Advancements to Fuel Growth in Protein Assay Market
    • Rising Demand in Biomedical research Propels Market Growth
    • Increasing Use in Drug Discovery and Development Expands Addressable Market Opportunity
    • Technological Advancements in Assay Sensitivity Strengthen Market Position
    • Growing Focus on Personalized Medicine Drives Adoption of Protein Assays
    • Surge in Demand for High-Throughput Screening Generates New Opportunities
    • Development of Multiplex Protein Assays Sustains Market Growth
    • Expanding Applications in Diagnostic Testing Throws Spotlight on Market Potential
    • Surge in Demand for Quantitative Proteomics Expands Market Horizons
    • Growing Awareness of Early Disease Detection Drives Market Adoption
    • Innovations in Microplate and Automated Assay Systems Generate New Market Opportunities
    • Rising Demand for Cost-Effective and Scalable Assay Solutions Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Protein Assays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Absorbance-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Absorbance-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Absorbance-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Colorimetric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Colorimetric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Colorimetric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fluorescence-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fluorescence-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Fluorescence-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: China 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: China 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: China 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Protein Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: France 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: France 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: France 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: France 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: UK 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Europe 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Europe 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Asia-Pacific 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Asia-Pacific 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of World 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of World 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of World 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of World 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030

IV. COMPETITION